These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19056767)

  • 41. Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation.
    Day SA; Lakner AM; Moore CC; Yen MH; Clemens MG; Wu ES; Schrum LW
    Biochem Pharmacol; 2011 Apr; 81(8):996-1003. PubMed ID: 21291870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
    Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
    Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction.
    Tawfik MK; Ghattas MH; Abo-Elmatty DM; Abdel-Aziz NA
    Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):499-506. PubMed ID: 20712256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells.
    Pantan R; Tocharus J; Suksamrarn A; Tocharus C
    Exp Cell Res; 2016 Mar; 342(2):104-12. PubMed ID: 26957227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells.
    Schroecksnadel K; Frick B; Winkler C; Wirleitner B; Weiss G; Fuchs D
    Clin Chem Lab Med; 2005; 43(12):1373-6. PubMed ID: 16309375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
    Rosón MI; Cao G; Della Penna S; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects.
    Schindler C; Brosnihan KB; Ferrario CM; Bramlage P; Maywald U; Koch R; Oertel R; Kirch W
    J Clin Pharmacol; 2007 Jan; 47(1):112-20. PubMed ID: 17192509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L; Rebollo A; Ađalsteisson GS; Alegret M; Merlos M; Roglans N; Laguna JC
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):32-40. PubMed ID: 21122807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing the effectiveness of tyrosine kinase inhibitor (TKI) in combination with a statin in reducing liver fibrosis.
    Mohammadalipour A; Hashemnia M; Goudarzi F; Ravan AP
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1183-1193. PubMed ID: 31396972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake.
    Fiore MC; Jimenez PM; Cremonezzi D; Juncos LI; García NH
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F263-70. PubMed ID: 21543414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models.
    Cui W; Matsuno K; Iwata K; Ibi M; Katsuyama M; Kakehi T; Sasaki M; Ikami K; Zhu K; Yabe-Nishimura C
    J Pharmacol Sci; 2009 Nov; 111(3):260-8. PubMed ID: 19881226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.
    Ruiz-Ortega M; Ruperez M; Lorenzo O; Esteban V; Blanco J; Mezzano S; Egido J
    Kidney Int Suppl; 2002 Dec; (82):S12-22. PubMed ID: 12410849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory signaling in pulmonary arterial hypertension: the controversial role of CRP, and the search for new therapies.
    Maciocia PM
    Cardiovasc Ther; 2010; 28(1):1-4. PubMed ID: 20074252
    [No Abstract]   [Full Text] [Related]  

  • 55. Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice.
    Kesh SB; Sikder K; Manna K; Das DK; Khan A; Das N; Dey S
    Life Sci; 2013 May; 92(17-19):938-49. PubMed ID: 23567805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of attenuation of pro-inflammatory Ang II-induced NF-κB activation by genistein in the kidneys of male rats during aging.
    Kim JM; Uehara Y; Choi YJ; Ha YM; Ye BH; Yu BP; Chung HY
    Biogerontology; 2011 Dec; 12(6):537-50. PubMed ID: 21713398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atorvastatin affects several angiogenic mediators in human endothelial cells.
    Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
    Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.
    Ortego M; Bustos C; Hernández-Presa MA; Tuñón J; Díaz C; Hernández G; Egido J
    Atherosclerosis; 1999 Dec; 147(2):253-61. PubMed ID: 10559511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
    Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
    Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.